AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12131561 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 10958373 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.9% carbohydrate-electrolyte solution (CES)
Number of subjects: 13
Study 10958373 — intervention group
Group type: COMPARATOR
Intervention: Sweetened placebo (P)
Number of subjects: 13
Study 9026563 — intervention group
Group type: EXPERIMENTAL
Intervention: Serotonin in blood
Number of subjects: 12
Study 9026563 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12
Study 1610425 — intervention group
Group type: EXPERIMENTAL
Intervention: Film-coated tablet
Number of subjects: 11
Study 1610425 — intervention group
Group type: EXPERIMENTAL
Intervention: New enteric-coated pellet preparation
Number of subjects: 11
Study 6703637 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligation alone
Number of subjects: 103
Study 6703637 — intervention group
Group type: COMPARATOR
Intervention: Ligation and invagination
Number of subjects: 103
Study 30497904 — intervention group
Group type: EXPERIMENTAL
Intervention: SB spray
Number of subjects: 52
Study 30107350 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg intravenous (IV) ketamine
Number of subjects: 5
Study 26481928 — intervention group
Group type: EXPERIMENTAL
Intervention: Stavudine
Number of subjects: 480
Study 26481928 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 480
Study 26481928 — intervention group
Group type: EXPERIMENTAL
Intervention: Abacavir
Number of subjects: 480
Study 25410451 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline and aerobic exercise
Number of subjects: 60
Study 25410451 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline alone
Number of subjects: 60
Study 23082557 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine (400 mg/day)
Number of subjects: 124
Study 23082557 — intervention group
Group type: EXPERIMENTAL
Intervention: Efavirenz (600 mg/day)
Number of subjects: 124
Study 23082557 — intervention group
Group type: COMPARATOR
Intervention: Nevirapine and Efavirenz
Number of subjects: 124
Study 20224868 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide and bupivacaine
Number of subjects: 100
Study 20224868 — intervention group
Group type: COMPARATOR
Intervention: Control group (bupivacaine or triamcinolone acetonide alone)
Number of subjects: 100
Study 18626267 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (10 mg/d)
Number of subjects: 54
Study 18626267 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine (25 mg/d)
Number of subjects: 54
Study 18626267 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 18626267 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram vs Clomipramine
Number of subjects: 54
Study 18626267 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment groups (Citalopram and Clomipramine)
Number of subjects: 54
Study 15756251 — intervention group
Group type: EXPERIMENTAL
Intervention: Various interventions in cancer trials (specific interventions not detailed in the abstract)
Number of subjects: 520
Study 12095510 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-assisted hatching (n = 85)
Number of subjects: 141
Study 12095510 — intervention group
Group type: COMPARATOR
Intervention: Chemical-assisted hatching (n = 56)
Number of subjects: 141
Study 10331828 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime treatment (postintervention)
Number of subjects: 85
Study 10331828 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime treatment (preintervention)
Number of subjects: 85
Study 7490172 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injections of 750 mcg of somatostatin 14 (SST14) at 15-day intervals
Number of subjects: 16
Study 7490172 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injections of 750 mcg of somatostatin 14 (SST14)
Number of subjects: 16
Study 30312272 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigation-assisted screw fixation (NSF)
Number of subjects: 52
Study 30312272 — intervention group
Group type: COMPARATOR
Intervention: Navigation-assisted screw fixation with additional sacroplasty (NSF + SP)
Number of subjects: 52
Study 29081428 — intervention group
Group type: EXPERIMENTAL
Intervention: CMIground
Number of subjects: 68
Study 29081428 — intervention group
Group type: COMPARATOR
Intervention: CMIfloat
Number of subjects: 68
Study 25617046 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 30
Study 25617046 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet with Realsil complex
Number of subjects: 30
Study 25617046 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study 23378467 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostamatinib 100 mg bid
Number of subjects: 457
Study 23378467 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostamatinib 100 mg qd
Number of subjects: 457
Study 23378467 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 457
Study 21548951 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Electromagnetic Fields bone growth stimulating device (active)
Number of subjects: 0
Study 21548951 — intervention group
Group type: COMPARATOR
Intervention: Disabled Pulsed Electromagnetic Fields bone growth stimulating device (placebo)
Number of subjects: 0
Study 19046200 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial factors (night duty, stress, administrative position)
Number of subjects: 128
Study 19046200 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower fasting plasma glucose (FPG) levels, being a white-collar worker, non-smoking, lower serum alanine aminotransferase (ALT) levels
Number of subjects: 128
Study 15943851 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of famotidine (40 mg/day)
Number of subjects: 400
Study 15943851 — intervention group
Group type: COMPARATOR
Intervention: Drip infusion of omeprazole (40 mg/day)
Number of subjects: 400
Study 12600912 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylcysteine (600 mg BID)
Number of subjects: 134
Study 12600912 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study 10846331 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 micrograms misoprostol vaginally at home (self-administered)
Number of subjects: 22
Study 9387637 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing exercises (BE)
Number of subjects: 324
Study 9387637 — intervention group
Group type: COMPARATOR
Intervention: Placebo medicine (Control)
Number of subjects: 324
Study 2039616 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy storing prosthetic feet (Seattle and Flex feet)
Number of subjects: 10
Study 2039616 — intervention group
Group type: COMPARATOR
Intervention: SACH foot
Number of subjects: 10
Study 6481116 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of prednisone (oral dose)
Number of subjects: 18
Study 30760248 — intervention group
Group type: EXPERIMENTAL
Intervention: QUiPP app
Number of subjects: 0
Study 30760248 — intervention group
Group type: COMPARATOR
Intervention: Control (standard management)
Number of subjects: 0
Study 29453222 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear lens extraction (CLE)
Number of subjects: 419
Study 26917681 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback intervention (structured feedback sessions)
Number of subjects: 35
Study 26917681 — intervention group
Group type: COMPARATOR
Intervention: Routine practice (control group)
Number of subjects: 35
Study 26917681 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback intervention
Number of subjects: 35
Study 24367796 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological male personnel
Number of subjects: 0
Study 24367796 — intervention group
Group type: EXPERIMENTAL
Intervention: Transgender researcher
Number of subjects: 0
Study 24367796 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor apparatus (ice cooler vs. refrigerated bath circulator)
Number of subjects: 0
Study 23117776 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg dexamethasone
Number of subjects: 4494
Study 23117776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4494
Study 20227579 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-pulsed neodymium:yttrium-aluminium-garnet laser treatment
Number of subjects: 22
Study 20227579 — intervention group
Group type: COMPARATOR
Intervention: Topical benzoyl peroxide and clindamycin (Control)
Number of subjects: 22
Study 20227579 — intervention group
Group type: EXPERIMENTAL
Intervention: Histologic examination
Number of subjects: 22
Study 20227579 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient satisfaction assessment
Number of subjects: 22
Study 18154905 — intervention group
Group type: EXPERIMENTAL
Intervention: diet/probiotics
Number of subjects: 256
Study 18154905 — intervention group
Group type: COMPARATOR
Intervention: diet/placebo
Number of subjects: 256
Study 18154905 — intervention group
Group type: COMPARATOR
Intervention: control/placebo
Number of subjects: 256
Study 15943650 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual nutrition education provided by a dietitian (6 sessions over 3 months)
Number of subjects: 51
Study 12181386 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (30 mg daily for 1 week)
Number of subjects: 8
Study 12181386 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 10338457 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 67
Study 10338457 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 67
Study 7574005 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 MAC isoflurane with subjects in the asleep state
Number of subjects: 9
Study 7574005 — intervention group
Group type: COMPARATOR
Intervention: 0.1 MAC isoflurane with subjects in the awake state
Number of subjects: 9
Study 7574005 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 MAC isoflurane during early hypoxia
Number of subjects: 9
Study 7574005 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 MAC isoflurane during late hypoxia
Number of subjects: 9
Study 1951997 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg suxamethonium
Number of subjects: 67
Study 1951997 — intervention group
Group type: COMPARATOR
Intervention: 0.5 mg/kg suxamethonium
Number of subjects: 67
Study 7019782 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release indomethacin capsules
Number of subjects: 0
Study 7019782 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin suppositories
Number of subjects: 0
Study 7019782 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral route of medication (sustained release indomethacin)
Number of subjects: 0
Study 31451704 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice bran extract supplement (RBS) 1,000 mg/day
Number of subjects: 50
Study 31451704 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 28135891 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial Splenic Embolization (PSE)
Number of subjects: 50
Study 28135891 — intervention group
Group type: COMPARATOR
Intervention: Splenectomy
Number of subjects: 50
Study 27523583 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 103
Study 27523583 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet among participants with baseline serum UA ≥7 mg/dl (n=8)
Number of subjects: 103
Study 27523583 — intervention group
Group type: COMPARATOR
Intervention: Medium sodium intake
Number of subjects: 103
Study 27523583 — intervention group
Group type: COMPARATOR
Intervention: High sodium intake
Number of subjects: 103
Study 24366395 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure drugs (β-blockers, diuretics, ACEIs/ARBs)
Number of subjects: 171097
Study 22484777 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockade (BB) therapy
Number of subjects: 280
Study 22484777 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 280
Study 22484777 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting HR>70 bpm
Number of subjects: 280
Study 20488486 — intervention group
Group type: EXPERIMENTAL
Intervention: Voiding cystourethrography and dimercapto-succinic acid scintigraphy at study entry and 2-year follow-up
Number of subjects: 203
Study 20488486 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive methods for lower urinary tract function assessment
Number of subjects: 203
Study 20488486 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of renal damage and recurrent urinary tract infections
Number of subjects: 203
Study 18568957 — intervention group
Group type: EXPERIMENTAL
Intervention: Heuristic rule training for 4 hours on a PC-based simulation of a process control task
Number of subjects: 39
Study 18568957 — intervention group
Group type: COMPARATOR
Intervention: Control group (no heuristic rule training)
Number of subjects: 39
Study 16649872 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose nicotine patch (35 mg)
Number of subjects: 324
Study 16649872 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 324
Study 12618645 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician opinion leader intervention (OL)
Number of subjects: 2210
Study 12618645 — intervention group
Group type: COMPARATOR
Intervention: Health Care Quality Improvement Program (HCQIP)
Number of subjects: 2210
Study 12618645 — intervention group
Group type: COMPARATOR
Intervention: No intervention (NI)
Number of subjects: 2210
Study 10373091 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural intervention
Number of subjects: 0
Study 10373091 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural intervention with posture correction
Number of subjects: 0
Study 10373091 — intervention group
Group type: COMPARATOR
Intervention: Non‐intervention control
Number of subjects: 0
Study 8913402 — intervention group
Group type: EXPERIMENTAL
Intervention: Emla cream (5%)
Number of subjects: 11
Study 8913402 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 1365487 — intervention group
Group type: EXPERIMENTAL
Intervention: droxicam 20mg/day
Number of subjects: 80
Study 1365487 — intervention group
Group type: COMPARATOR
Intervention: diclofenac sodium 150mg/day
Number of subjects: 80
Study 6341350 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotetan (1 or 2 g every 12 h)
Number of subjects: 0
Study 6341350 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin (1 or 2 g every 8 h)
Number of subjects: 0
Study 30099113 — intervention group
Group type: EXPERIMENTAL
Intervention: 50mg diclofenac potassium
Number of subjects: 129
Study 30099113 — intervention group
Group type: EXPERIMENTAL
Intervention: 20mg hyoscine-N-butyl bromide (HBB)
Number of subjects: 129
Study 30099113 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 30540772 — intervention group
Group type: EXPERIMENTAL
Intervention: Gratitude training
Number of subjects: 156
Study 30540772 — intervention group
Group type: EXPERIMENTAL
Intervention: Loving-kindness
Number of subjects: 156
Study 30540772 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath awareness
Number of subjects: 156
Study 30540772 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 156
Study 28722480 — intervention group
Group type: EXPERIMENTAL
Intervention: SAR342434 (SAR-Lis)
Number of subjects: 507
Study 28722480 — intervention group
Group type: COMPARATOR
Intervention: Insulin lispro (Ly-Lis)
Number of subjects: 507
Study 24957256 — intervention group
Group type: EXPERIMENTAL
Intervention: Regorafenib 160 mg daily plus best supportive care (BSC)
Number of subjects: 185
Study 24957256 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus best supportive care (BSC)
Number of subjects: 185
Study 24257332 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional gravitational valves
Number of subjects: 0
Study 24257332 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer duration of surgery
Number of subjects: 0
Study 24257332 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 0
Study 24257332 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmable valve exchange to gravitational valve
Number of subjects: 0
Study 20829335 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence at the time of death
Number of subjects: 226
Study 20829335 — intervention group
Group type: EXPERIMENTAL
Intervention: Older patient demographics
Number of subjects: 226
Study 20829335 — intervention group
Group type: EXPERIMENTAL
Intervention: Early family conferences
Number of subjects: 226
Study 20829335 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal of a ventilator ordered
Number of subjects: 226
Study 18309905 — intervention group
Group type: EXPERIMENTAL
Intervention: Radix astragali (RA)
Number of subjects: 10
Study 18309905 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 10
Study 17019683 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior stabilized prostheses
Number of subjects: 0
Study 17019683 — intervention group
Group type: COMPARATOR
Intervention: Cruciate retaining prostheses
Number of subjects: 0
Study 14658584 — intervention group
Group type: EXPERIMENTAL
Intervention: Monotherapy with platinum analogues
Number of subjects: 0
Study 14658584 — intervention group
Group type: EXPERIMENTAL
Intervention: Various combinations of cytostatic drugs
Number of subjects: 0
Study 14658584 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin/bleomycin/mitomycin C/vindesine, cisplatin/paclitaxel, cisplatin/irinotecan
Number of subjects: 0
Study 14658584 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluoruracil, ifosfamide, paclitaxel, or cisplatinum
Number of subjects: 0
Study 10720913 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% N-chlorotaurine (NCT) applied 5 times a day
Number of subjects: 9
Study 9061681 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated bednets (lambdacyhalothrin 10 mg/m2)
Number of subjects: 16
Study 9061681 — intervention group
Group type: COMPARATOR
Intervention: Control group (villages without nets)
Number of subjects: 16
Study 8117508 — intervention group
Group type: EXPERIMENTAL
Intervention: Early technetium‐99m methylene diphosphonate (99mTc‐MDP) scintimetry
Number of subjects: 84
Study 8117508 — intervention group
Group type: COMPARATOR
Intervention: Follow-up scintimetry after conservative treatment and osteosynthesis
Number of subjects: 84
Study 8117508 — intervention group
Group type: EXPERIMENTAL
Intervention: Scintimetry
Number of subjects: 84
Study 4027120 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal 50 g in 300 ml of water
Number of subjects: 6
Study 4027120 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal 50 g administered immediately after PAS 10 g or 20 g
Number of subjects: 6
Study 4027120 — intervention group
Group type: COMPARATOR
Intervention: Water only (control)
Number of subjects: 6
Study 29917069 — intervention group
Group type: COMPARATOR
Intervention: 0 µg/d vitamin D3
Number of subjects: 119
Study 29917069 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 µg/d vitamin D3
Number of subjects: 119
Study 29917069 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 µg/d vitamin D3
Number of subjects: 119
Study 27089843 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutritional support for 5 days (n=1200)
Number of subjects: 2400
Study 27089843 — intervention group
Group type: COMPARATOR
Intervention: Enteral nutritional support for 5 days (n=1200)
Number of subjects: 2400
Study 25856732 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated pulmonary rehabilitation (PR)
Number of subjects: 106
Study 22332940 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 0
Study 22332940 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 0
Study 20354718 — intervention group
Group type: EXPERIMENTAL
Intervention: Normoxic condition (F(I)O(2) 0.21)
Number of subjects: 13
Study 20354718 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute hypoxic condition (F(I)O(2) 0.13)
Number of subjects: 13
Study 20354718 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia
Number of subjects: 13
Study 20354718 — intervention group
Group type: COMPARATOR
Intervention: Normoxia
Number of subjects: 13
Study 18845972 — intervention group
Group type: EXPERIMENTAL
Intervention: Training under hypoxia (FiO2 = 15%)
Number of subjects: 20
Study 18845972 — intervention group
Group type: COMPARATOR
Intervention: Training under normoxia (FiO2 = 21%)
Number of subjects: 20
Study 16001319 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75 %
Number of subjects: 40
Study 16001319 — intervention group
Group type: COMPARATOR
Intervention: Prilocaine 1 %
Number of subjects: 40
Study 12215595 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent hemispheric stroke patients (left and right)
Number of subjects: 40
Study 12215595 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 40
Study 10521842 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystic hygroma (class 1)
Number of subjects: 1867
Study 10521842 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal atresia (class 2)
Number of subjects: 1867
Study 10521842 — intervention group
Group type: EXPERIMENTAL
Intervention: Holoprosencephaly (class 3)
Number of subjects: 1867
Study 10521842 — intervention group
Group type: EXPERIMENTAL
Intervention: Omphalocele (class 4)
Number of subjects: 1867
Study 7475658 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg primaquine base daily (double‐blinded)
Number of subjects: 126
Study 7475658 — intervention group
Group type: COMPARATOR
Intervention: Placebo (double‐blinded)
Number of subjects: 126
Study 7475658 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg chloroquine base weekly (open)
Number of subjects: 126
Study 1942917 — intervention group
Group type: EXPERIMENTAL
Intervention: Solcoseryl ophthalmic gel
Number of subjects: 18
Study 1942917 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.4% cysteine in ophthalmic gel
Number of subjects: 18
Study 463541 — intervention group
Group type: EXPERIMENTAL
Intervention: Short end‐hole catheter
Number of subjects: 71
Study 463541 — intervention group
Group type: EXPERIMENTAL
Intervention: Long side‐hole catheter
Number of subjects: 71
Study 463541 — intervention group
Group type: EXPERIMENTAL
Intervention: Short side‐hole catheter
Number of subjects: 71